![Frontiers | Five-lipoxygenase-activating protein-mediated CYLD attenuation is a candidate driver in hepatic malignant lesion Frontiers | Five-lipoxygenase-activating protein-mediated CYLD attenuation is a candidate driver in hepatic malignant lesion](https://www.frontiersin.org/files/Articles/912881/fonc-12-912881-HTML/image_m/fonc-12-912881-g001.jpg)
Frontiers | Five-lipoxygenase-activating protein-mediated CYLD attenuation is a candidate driver in hepatic malignant lesion
![Kai Schröder email address & phone number | Kappa Bioscience As Vice President Finance and Operations contact information - RocketReach Kai Schröder email address & phone number | Kappa Bioscience As Vice President Finance and Operations contact information - RocketReach](https://d1hbpr09pwz0sk.cloudfront.net/profile_pic/kai-schroder-6a30aed1.jpg)
Kai Schröder email address & phone number | Kappa Bioscience As Vice President Finance and Operations contact information - RocketReach
![Kai Schröder email address & phone number | Kappa Bioscience As Vice President Finance and Operations contact information - RocketReach Kai Schröder email address & phone number | Kappa Bioscience As Vice President Finance and Operations contact information - RocketReach](https://d1hbpr09pwz0sk.cloudfront.net/profile_pic/dominik-mattern-de9e7ba2.jpg)